0078-0650 : Farydak 10 mg Oral Capsule


NDC: 0078-0650
Labeler: Novartis Pharmaceuticals Corporation
Product Type: Human Prescription Drug
Drug Name:  Farydak
Dosage Form: Oral Capsule
Application #: NDA205353
Rev. Date: 


Appearance:


Markings: LBH;10;mg
Shapes:  Capsule
Colors:  Green
Size (mm): 16
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 0078-0650-06: 6 CAPSULE IN 1 BLISTER PACK (0078‑0650‑06)

Active Ingredients:

  • Panobinostat Lactate

Dosage Strength:

  • 10 mg

Inactive Ingredients:

  • Magnesium Stearate
  • Mannitol
  • Cellulose, Microcrystalline
  • Starch, Corn

Pharmaceutical Classes:

  • Histone Deacetylase Inhibitor [EPC]
  • Histone Deacetylase Inhibitors [MoA]
  • Cytochrome P450 2D6 Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0078-0651 Farydak 15 mg Oral Capsule by Novartis Pharmaceuticals Corporation
  • 0078-0652 Farydak 20 mg Oral Capsule by Novartis Pharmaceuticals Corporation
  • 73116-100 Farydak 10 mg Oral Capsule by Secura Bio, Inc.
  • 73116-101 Farydak 15 mg Oral Capsule by Secura Bio, Inc.
  • 73116-102 Farydak 20 mg Oral Capsule by Secura Bio, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0078-0650 QR Code

< Prev: 0078-0649Next: 0078-0651 >

Related Discussions:

Lactated Ringer's Solution
Iv Medication...
lactated ringers
used for c-section...
calcium lactate
Functions of intake of calcium lactate....
ringers lactate
OB drug...
ammonium lactate cream 12%
topical cream...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.